The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists

Fundamental and Clinical Pharmacology

Volumn 18, Issue 3, 2004, Pages 309-319

  Nap, Alexander ^a   Mathy, Marie Jeanne ^a   Balt, Jippe C ^a   Pfaffendorf, Martin ^a   Van Zwieten, Pieter A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

1,4 dihydropyridine calcium 3H noradrenaline; Antagonist; Arteries; Cilnidipine; Heart; N type calcium channel

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL N TYPE; CILNIDIPINE; MIBEFRADIL; NORADRENALIN; OMEGA CONOTOXIN GVIA; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SELECTIVITY; ELECTROSTIMULATION; EVOKED RESPONSE; HEART RATE; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SPINAL ANIMAL; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; ARTERIES; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; DECEREBRATE STATE; DIHYDROPYRIDINES; ELECTRIC STIMULATION; HEART; HEART RATE; MALE; NOREPINEPHRINE; RABBITS; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOLYTICS; VASOCONSTRICTION;

EID: 2942580721     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2004.00236.x     Document Type: Article

References (30)

1. Opie L.H. Calcium channel blockers in hypertension: reappraisal after new trials and major meta-analyses. Am. J. Hypertens. (2001) 14 1074-1081.
2. Gattis W., O'Connor C.M. Calcium antagonists in the treatment of heart failure. Re-evaluation of therapeutic strategies. Drugs (2000) 59 17-24.
3. Elkayam U. Calcium channel blockers in heart failure. Cardiology (1998) 89 (Suppl. 1) 38-46.
4. Muntwyler J., Follath F. Calcium channel blockers in treatment of hypertension. Prog. Cardiovasc. Dis. (2001) 44 207-216.
5. De Leeuw P.W., Birkenhager W.H. The effects of calcium channel blockers on cardiovascular outcomes: a review of randomised controlled trials. Blood Press. (2002) 11 71-78.
6. Serruys P.W., Brower R.W., ten Katen H.J., Bom A.H., Hugenholtz P.G. Regional wall motion from radiopaque markers after intravenous and intracoronary injections of nifedipine. Circulation (1981) 63 584-591.
7. Theroux P., Waters D.D., Debaisieux J.C., Szlachcic J., Mizgala H.F., Bourassa M.G. Hemodynamic effects of calcium ion antagonists after acute myocardial infarction. Clin. Invest. Med. (1980) 3 81-85.
8. Burges R., Moisey D. Unique pharmacologic properties of amlodipine. Am. J. Cardiol. (1994) 73 2A-9A.
9. Micheli D., Ratti E., Toson G., Gaviraghi G. Pharmacology of lacidipine, a vascular-selective calcium antagonist. J. Cardiovasc. Pharmacol. (1991) 17 (Suppl. 4) S1-S8.
10. Herbette L.G., Vecchiarelli M., Sartani A., Leonardi A. Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties. Blood Press. (1998) 2 10-17.
11. Zhou X., Ono H., Ono Y., Frohlich E.D. N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an 1-NAME/SHR model. J. Hypertens. (2002) 20 993-1000.
12. Murai Y., Uneyama H., Ishibashi H., Takahama K., Akaike N. Preferential inhibition of L- and N-type calcium channels in the rat hippocampal neurons by cilnidipine. Brain Res. (2000) 854 6-10.
13. Hirning L.D., Fox A.P., McCleskey E.W. et al. Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurons. Science (1988) 239 57-61.
14. Wright C.E., Angus J.A. Effects of N-, P- and Q-type neuronal calcium channel antagonists on mammalian peripheral neurotransmission. Br. J. Pharmacol. (1996) 119 49-56.
15. Fujii S., Kameyama K., Hosono M., Hayashi Y., Kitamura K. Effect of cilnidipine, a novel dihydropyridine Ca++-channel antagonist, on N-type Ca++ channel in rat dorsal root ganglion neurons. J. Pharmacol. Exp. Ther. (1997) 280 1184-1191.
16. Hosono M., Hiruma T., Watanabe K. et al. Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats. Jpn. J. Pharmacol. (1995) 69 119-125.
17. Sakata K., Shirotani M., Yoshida H. et al. Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension. Hypertension (1999) 33 1447-1452.
18. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. (1977) 41 19-26.
19. van der L.R., Pfaffendorf M., De Mey J.G., van Zwieten P.A. Inhibitory effect of mibefradil on contractions induced by sympathetic neurotransmitter release in the rat tail artery. Naunyn Schmiedebergs Arch. Pharmacol. (2000) 361 74-79.
20. Nap A., Pfaffendorf M., van Zwieten P. Characterisation of a modified approach to the study of sympathetic neurotransmission and its presynaptic modulation in the isolated rabbit thoracic aorta. J. Pharmacol Toxicol Methods (2001) 46 (3) 145-151.
21. Hosono M., Fujii S., Hiruma T. et al. Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats. Jpn. J. Pharmacol. (1995) 69 127-134.
22. Molderings G.J., Likungu J., Gothert M. N-Type calcium channels control sympathetic neurotransmission in human heart atrium. Circulation (2000) 101 403-407.
23. Kato K., Wakamori M., Mori Y., Imoto K., Kitamura K. Inhibitory effects of cilnidipine on peripheral and brain N-type Ca(2+) channels expressed in BHK cells. Neuropharmacology (2002) 42 1099-1108.
24. Uneyama H., Takahara A., Dohmoto H., Yoshimoto R., Inoue K., Akaike N. Blockade of N-type Ca2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones. Br. J. Pharmacol. (1997) 122 37-42.
25. Pruneau D., Angus J.A. Apparent vascular to cardiac sympatholytic selectivity of omega-conotoxin GVIA in the pithed rat. Eur. J. Pharmacol. (1990) 184 127-133.
26. Konda T., Takahara A., Maeda K., Dohmoto H., Yoshimoto R. Effects of a dual L/N-type Ca(2+) channel blocker cilnidipine on neurally mediated chronotropic response in anesthetized dogs. Eur. J. Pharmacol. (2001) 413 117-120.
27. Boyett M.R., Honjo H., Kodama I. The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc. Res. (2000) 47 658-687.
28. Verheijck E.E., van Ginneken A.C., Wilders R., Bouman L.N. Contribution of L-type Ca2+ current to electrical activity in sinoatrial nodal myocytes of rabbits. Am. J. Physiol. (1999) 276 H1064-H1077.
29. Protas L., Robinson R.B. Mibefradil, an I(Ca,T) blocker, effectively blocks I(Ca,L) in rabbit sinus node cells. Eur. J. Pharmacol. (2000) 401 27-30.
30. Uchida R., Yamazaki J., Ozeki S., Kitamura K. State-dependent inhibition of L-type Ca2+ channels in A7r5 cells by cilnidipine and its derivatives. Jpn. J. Pharmacol. (2001) 85 260-270.